Hyfusin Group Holdings Limited (8512.HK)
HKD 0.32
(0.0%)
HKD 0.32
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 181.34 Million HKD | 84.94% |
| 2022 | 98.05 Million HKD | -35.71% |
| 2021 | 152.52 Million HKD | 17.8% |
| 2020 | 129.48 Million HKD | 34.25% |
| 2019 | 96.45 Million HKD | 69.27% |
| 2018 | 56.98 Million HKD | -14.68% |
| 2017 | 66.78 Million HKD | 14.27% |
| 2016 | 58.44 Million HKD | 25.26% |
| 2015 | 46.66 Million HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 196.7 Million HKD | 0.0% |
| 2024 Q1 | 196.7 Million HKD | 8.47% |
| 2023 Q2 | 184.54 Million HKD | 0.0% |
| 2023 Q1 | - HKD | -100.0% |
| 2023 FY | 181.34 Million HKD | 84.94% |
| 2023 Q4 | 181.34 Million HKD | 0.0% |
| 2023 Q3 | - HKD | -100.0% |
| 2022 Q1 | - HKD | -100.0% |
| 2022 FY | 98.05 Million HKD | -35.71% |
| 2022 Q4 | 98.05 Million HKD | 0.0% |
| 2022 Q3 | - HKD | -100.0% |
| 2022 Q2 | 151.54 Million HKD | 0.0% |
| 2021 Q4 | 152.52 Million HKD | 0.0% |
| 2021 Q2 | 170.38 Million HKD | 0.0% |
| 2021 FY | 152.52 Million HKD | 17.8% |
| 2021 Q1 | - HKD | -100.0% |
| 2020 Q4 | 129.48 Million HKD | 0.0% |
| 2020 Q2 | 105.06 Million HKD | 0.0% |
| 2020 FY | 129.48 Million HKD | 34.25% |
| 2020 Q1 | - HKD | -100.0% |
| 2019 Q1 | - HKD | -100.0% |
| 2019 FY | 96.45 Million HKD | 69.27% |
| 2019 Q4 | 96.45 Million HKD | 0.0% |
| 2019 Q2 | 71.47 Million HKD | 0.0% |
| 2018 Q4 | 56.98 Million HKD | 0.0% |
| 2018 FY | 56.98 Million HKD | -14.68% |
| 2018 Q2 | 73 Million HKD | 0.0% |
| 2018 Q1 | - HKD | -100.0% |
| 2017 FY | 66.78 Million HKD | 14.27% |
| 2017 Q1 | - HKD | 0.0% |
| 2017 Q4 | 66.78 Million HKD | 0.0% |
| 2016 FY | 58.44 Million HKD | 25.26% |
| 2015 FY | 46.66 Million HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 308.05 Million HKD | 41.132% |
| Innovative Pharmaceutical Biotech Limited | 1.06 Billion HKD | 82.949% |
| China Overseas Nuoxin International Holdings Limited | 109.1 Million HKD | -66.22% |
| Prosperous Future Holdings Limited | 177.1 Million HKD | -2.393% |
| Huasheng International Holding Limited | 675.58 Million HKD | 73.157% |
| Fourace Industries Group Holdings Limited | 61.8 Million HKD | -193.42% |
| Evergreen Products Group Limited | 786.46 Million HKD | 76.941% |
| EC Healthcare | 2.97 Billion HKD | 93.895% |
| Ming Fai International Holdings Limited | 772.01 Million HKD | 76.51% |
| Blue Moon Group Holdings Limited | 1.61 Billion HKD | 88.791% |
| SuperRobotics Holdings Limited | 172.27 Million HKD | -5.268% |
| Takbo Group Holdings Limited | 42.84 Million HKD | -323.226% |